home / stock / psil / psil quote
Last: | $1.255 |
---|---|
Change Percent: | 0.0% |
Open: | $1.24 |
Close: | $1.255 |
High: | $1.255 |
Low: | $1.23 |
Volume: | 22,696 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.255 | $1.24 | $1.255 | $1.255 | $1.23 | 22,696 | 04-26-2024 |
$1.24 | $1.23 | $1.24 | $1.24 | $1.21 | 43,824 | 04-25-2024 |
$1.24 | $1.26 | $1.24 | $1.27 | $1.24 | 23,298 | 04-24-2024 |
$1.28 | $1.25 | $1.28 | $1.28 | $1.25 | 17,192 | 04-23-2024 |
$1.255 | $1.22 | $1.255 | $1.2599 | $1.22 | 35,533 | 04-22-2024 |
$1.24 | $1.27 | $1.24 | $1.28 | $1.2 | 91,700 | 04-19-2024 |
$1.28 | $1.28 | $1.28 | $1.32 | $1.25 | 184,986 | 04-18-2024 |
$1.31 | $1.33 | $1.31 | $1.3599 | $1.29 | 120,735 | 04-17-2024 |
$1.35 | $1.35 | $1.35 | $1.36 | $1.32 | 90,539 | 04-16-2024 |
$1.375 | $1.41 | $1.375 | $1.41 | $1.37 | 31,250 | 04-15-2024 |
$1.37 | $1.44 | $1.37 | $1.464 | $1.357 | 94,740 | 04-12-2024 |
$1.45 | $1.48 | $1.45 | $1.48 | $1.4301 | 72,741 | 04-11-2024 |
$1.435 | $1.43 | $1.435 | $1.45 | $1.43 | 59,773 | 04-10-2024 |
$1.4606 | $1.51 | $1.4606 | $1.51 | $1.45 | 168,619 | 04-09-2024 |
$1.51 | $1.54 | $1.51 | $1.54 | $1.4902 | 84,281 | 04-08-2024 |
$1.4905 | $1.53 | $1.4905 | $1.53 | $1.4801 | 52,364 | 04-05-2024 |
$1.51 | $1.55 | $1.51 | $1.57 | $1.5 | 102,980 | 04-04-2024 |
$1.54 | $1.47 | $1.54 | $1.54 | $1.45 | 88,938 | 04-03-2024 |
$1.45 | $1.48 | $1.45 | $1.48 | $1.43 | 40,753 | 04-02-2024 |
$1.49 | $1.53 | $1.49 | $1.53 | $1.44 | 99,622 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
AdvisorShares Psychedelics ETF Company Name:
PSIL Stock Symbol:
NYSE Market:
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned ...
Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Results of a first-in-class clinical trial on ibogaine-magnesium th...
Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Results of a first-in-class clinical trial on ibogaine-magnesium th...